Environmental Cadmium Exposure Exacerbated Bone Loss in NAFLD Mice

Overview

Journal Biol Trace Elem Res

Date 2023 Dec 15

PMID 38100013

Authors

Changhao Li

Nana Wang

Yuting Li

Hui Yang

Jiafu Li

Zengli Zhang

Affiliations

Soon will be listed here.

Abstract

Due to rapid urbanization and industrialization, Cadmium (Cd) contamination is widespread. Meanwhile, the prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing. Cd is linked to bone damage. However, the osteotoxicity of environmental Cd exposure in NAFLD remains unclear. Therefore, this study aimed to investigate the effects and potential mechanisms of Cd on bone metabolism in NAFLD mice. NAFLD mice were treated with 50 mg/L cadmium chloride in drinking water for 12 weeks. Bone microstructures were scanned by Micro-CT. Liver lipid droplets and fibrosis were measured by histopathological staining. Insulin tolerance tests were performed in mice. RT-PCR and Western blot were performed to analyse hepatic inflammation factors. Results show no damage in healthy mice exposed to Cd. However, Cd exacerbated liver fibrosis and significantly reduced cancellous bone mineral density and decreased the number and thickness of trabecular bone in NAFLD mice. Additionally, the morphology of trabecular bone transformed from a plate structure to a rod structure in NAFLD mice after Cd exposure. The underlying mechanism appears to be related to the Cd-induced direct or indirect toxicity. Exacerbated liver fibrosis, increased inflammatory factors (TGF-β and IL-1β), and reduced lecithin-cholesterol acyltransferase (LCAT) and insulin-like growth factor-1 (IGF-1) might contribute to bone damages. Collectively, our study illustrates that despite lower dosing Cd exposure did not induce bone damages in healthy mice, Cd caused bone loss in NAFLD mice. Therefore, it is recommended that individuals with metabolic disorders should avoid working in Cd pollution environment and consuming cadmium-contaminated food and water.

References

He X, Gao J, Hou H, Qi Z, Chen H, Zhang X . Inhibition of Mitochondrial Fatty Acid Oxidation Contributes to Development of Nonalcoholic Fatty Liver Disease Induced by Environmental Cadmium Exposure. Environ Sci Technol. 2019; 53(23):13992-14000. DOI: 10.1021/acs.est.9b05131. View

Choudhury H, Harvey T, Thayer W, Lockwood T, Stiteler W, Goodrum P . Urinary cadmium elimination as a biomarker of exposure for evaluating a cadmium dietary exposure--biokinetics model. J Toxicol Environ Health A. 2001; 63(5):321-50. DOI: 10.1080/15287390152103643. View

Horiguchi H, Aoshima K, Oguma E, Sasaki S, Miyamoto K, Hosoi Y . Latest status of cadmium accumulation and its effects on kidneys, bone, and erythropoiesis in inhabitants of the formerly cadmium-polluted Jinzu River Basin in Toyama, Japan, after restoration of rice paddies. Int Arch Occup Environ Health. 2010; 83(8):953-70. DOI: 10.1007/s00420-010-0510-x. View

Osada M, Izuno T, Kobayashi M, Sugita M . Relationship between environmental exposure to cadmium and bone metabolism in a non-polluted area of Japan. Environ Health Prev Med. 2011; 16(6):341-9. PMC: 3206976. DOI: 10.1007/s12199-010-0204-8. View

Brzoska M, Majewska K, Kupraszewicz E . Effects of low, moderate and relatively high chronic exposure to cadmium on long bones susceptibility to fractures in male rats. Environ Toxicol Pharmacol. 2011; 29(3):235-45. DOI: 10.1016/j.etap.2010.01.005. View

Cobbina E, Akhlaghi F . Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017; 49(2):197-211. PMC: 5576152. DOI: 10.1080/03602532.2017.1293683. View

Loomba R, Sanyal A . The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013; 10(11):686-90. DOI: 10.1038/nrgastro.2013.171. View

Godoy-Lugo J, Thorwald M, Hui D, Nishiyama A, Nakano D, Sonanez-Organis J . Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats. Endocrine. 2021; 75(1):92-107. PMC: 8763929. DOI: 10.1007/s12020-021-02834-7. View

Poggiogalle E, Donini L, Lenzi A, Chiesa C, Pacifico L . Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle. World J Gastroenterol. 2017; 23(10):1747-1757. PMC: 5352914. DOI: 10.3748/wjg.v23.i10.1747. View

10.

Kim G, Kim K, Rhee Y, Lim S . Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. PLoS One. 2017; 12(7):e0182202. PMC: 5536288. DOI: 10.1371/journal.pone.0182202. View

11.

Bagi C, Edwards K, Berryman E . Metabolic Syndrome and Bone: Pharmacologically Induced Diabetes has Deleterious Effect on Bone in Growing Obese Rats. Calcif Tissue Int. 2017; 102(6):683-694. PMC: 5956015. DOI: 10.1007/s00223-017-0367-z. View

12.

He X, Qi Z, Hou H, Qian L, Gao J, Zhang X . Structural and functional alterations of gut microbiome in mice induced by chronic cadmium exposure. Chemosphere. 2020; 246:125747. DOI: 10.1016/j.chemosphere.2019.125747. View

13.

Porrelli D, Abrami M, Pelizzo P, Formentin C, Ratti C, Turco G . Trabecular bone porosity and pore size distribution in osteoporotic patients - A low field nuclear magnetic resonance and microcomputed tomography investigation. J Mech Behav Biomed Mater. 2021; 125:104933. DOI: 10.1016/j.jmbbm.2021.104933. View

14.

Lu K, Shi T, Shen S, Shi Y, Gao H, Wu J . Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression. Cell Metab. 2022; 34(3):441-457.e7. DOI: 10.1016/j.cmet.2022.02.006. View

15.

Barchetta I, Lubrano C, Cimini F, Dule S, Passarella G, Dellanno A . Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease. Hepatol Int. 2022; 17(2):357-366. DOI: 10.1007/s12072-022-10461-1. View

16.

Nussler A, Wildemann B, Freude T, Litzka C, Soldo P, Friess H . Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis. Arch Toxicol. 2014; 88(4):997-1006. DOI: 10.1007/s00204-013-1191-5. View

17.

Giustina A, Mazziotti G, Canalis E . Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008; 29(5):535-59. PMC: 2726838. DOI: 10.1210/er.2007-0036. View

18.

Triantaphyllidou I, Kalyvioti E, Karavia E, Lilis I, Kypreos K, Papachristou D . Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet. Osteoarthritis Cartilage. 2012; 21(2):322-30. DOI: 10.1016/j.joca.2012.11.003. View

19.

George J, Ganesh H, Acharya S, Bandgar T, Shivane V, Karvat A . Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009; 15(28):3516-22. PMC: 2715978. DOI: 10.3748/wjg.15.3516. View

20.

Zaidi M, Yuen T, Iqbal J . Reverse cholesterol transport and hepatic osteodystrophy. Cell Metab. 2022; 34(3):347-349. PMC: 11658025. DOI: 10.1016/j.cmet.2022.02.007. View